The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification.EBI
Universidade Federal De Minas Gerais
Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones.EBI
Universidade Federal De Minas Gerais
Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.EBI
Universidade Federal De Minas Gerais
Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19.EBI
Universidade Federal de Minas Gerais
Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles.EBI
Universidade Federal de Minas Gerais
Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds.EBI
Universidade Federal De Minas Gerais
Structure-activity relationships of novel inhibitors of glyceraldehyde-3-phosphate dehydrogenase.EBI
Universidade Federal De Minas Gerais
Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.EBI
Universidade Federal De Minas Gerais
In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors.EBI
Universidade Federal De Minas Gerais